AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts

The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.

Read more

Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.

Read more

Menacing Assaults on Science Causing Alarming and Avoidable Deaths in the U.S.

In early 2016, the U.S. was judged to have been best prepared for the existential threat of a pandemic, but turned out to be the least prepared for the actual threat. In a commentary, researchers say that “pandemic politics” is causing assaults on science, the FDA and CDC. They say that politicization of the FDA and CDC is creating continued losses of trust by the U.S. public and continued harm to their longstanding reputations of respect and admiration worldwide.

Read more

Morristown Medical Center’s Dr. Stephen Winters Discusses What Everyone Should Know About Atrial Fibrillation

September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.

Read more

CDC Data Shows E-cigarette Makers Continues to Prey on Youth – and FDA Policy Lets Them

Today, the CDC released data from the National Youth Tobacco Survey showing that in 2020, 20 percent of high school students and nearly 5 percent of middle school students used e-cigarettes. Most concerning, the data shows that among youth e-cigarette users, 38.9 percent of high school students and 20 percent of middle school students reported using e-cigarettes on 20 or more of the past 30 days; 22.5 percent of high school users and 9.4 percent of middle school users reported daily use.

Read more

AACC and CDC Partner to Improve Cardiovascular Disease Testing Around the World

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation that aims to expand lipid testing in resource-limited countries. Improving access to this essential testing could help reduce the high worldwide mortality rate from cardiovascular disease by enabling patients to get treated for this condition earlier.

Read more

ATS Statement on Latest COVID-19 Policy Actions: Convalescent Plasma and Testing of Asymptomatic Patients

The American Thoracic Society is alarmed by two federal agency policy actions that may significantly impact our nation’s COVID-19 response. This week, the FDA issued an emergency use authorization (EUA) for the use of convalescent plasma to treat COVID-19 disease. This action was taken despite a lack of adequate evidence demonstrating a clear benefit for most patients. As pulmonary and critical care clinicians and researchers who treat individuals with COVID-19, we are concerned that an EUA for convalescent plasma has the potential to put patients at risk.

Read more

COVID-19: How South Korea Prevailed While the U.S. Failed

In a commentary, researchers demonstrate the stark differences in public health strategies from two democratic republics: South Korea and the United States, which have led to alarming differences in cases and deaths from COVID-19. After adjusting for the 6.5 fold differences in populations, the U.S. has suffered 47 times more cases and 79 times more deaths than South Korea.

Read more

Back to School?

Dr. Terry Adirim provides answers to some of the most frequently asked questions regarding COVID-19 and return to school for school-age children. Adirim is a physician executive with senior leadership and executive experience in academic medicine and the federal government. Her expertise includes pandemic planning and response, health care quality improvement and patient safety, and health policy and management.

Read more